GL1X · GenesisL1 explorer

UniProt Q96CG3

15-mer peptide from TRAF-interacting protein with FHA domain-containing protein A (Q96CG3)

15-mer peptide from TRAF-interacting protein with FHA domain-containing protein A (UniProt Q96CG3): 8 experimental structures and 1 predicted model on GenesisL1. Binding sites, druggability and experiment against prediction…

UniProt
Q96CG3
Protein
15-mer peptide from TRAF-interacting protein with FHA domain-containing protein…
Experimental structures
8
Predicted models
1

Structures

9 records of Q96CG3 in the MolNFT archive: 8 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
4YM4Truncated Human TIFA in complex with its Thr9 phosphorylated N-terminal peptide 1-15x-ray diffractionA, B——
4YM4Truncated human tifa in complex with its THR9 phosphorylated N- terminal peptide 1-15x-ray diffractionA, B——
4ZGIStructure of Truncated Human TIFAx-ray diffractionA——
4ZGIStructure of truncated human tifax-ray diffractionA——
5ZUJBinding and Enhanced Binding between Key Immunity Proteins TRAF6 and TIFAx-ray diffractionI——
5ZUJBinding and enhanced binding between key immunity proteins TRAF6 and tifax-ray diffractionI——
6A33Binding and Enhanced Binding between Key Immunity Proteins TRAF6 and TIFAx-ray diffractionI——
6A33Binding and enhanced binding between key immunity proteins TRAF6 and tifax-ray diffractionI——
Q96CG3AlphaFold monomer V2.0 prediction for traf-interacting protein with fha domain-containing protein a…predictedA——

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.